How to best encourage private sector investors to invest in Land Degradation Neutrality

How to best encourage private sector investors to invest in Land Degradation Neutrality

“How to best encourage private sector investors to invest in Land Degradation Neutrality” is the title of the Master thesis of Tony Reyhanloo, which he successfully defended in December, 2016 at University of Zurich. The results of his thesis identify very promising insights into how…

Continue reading →

Big Data, Digital Transformation & the Role of the CLO

Big Data, Digital Transformation & the Role of the CLO

We are excited to announce that we will contribute as panel members to an Executive Knowledge Event on the topic of “Leading in Learning Europe” organized by iVentiv on September 27-28 in Basel, Switzerland. As panellists we will contribute to the discussion on how large…

Continue reading →

Workflow automation

Workflow automation

Lately, I was asked to develop a workflow automation to trigger a message alert once a predefined spot price is reached. I found these examples of Ron de Bruin an excellent starting point. I combined these VBA code examples with the Real Time Data (RTD)…

Continue reading →

Transactions – MANIFESTA11 Parallel Event: What people do for money

Transactions – MANIFESTA11 Parallel Event: What people do for money

MANIFESTA11. This year the European Biennial of Contemporary Art will be hosted in Zurich, Switzerland (11.6-18.9.2016) on the topic of “What people do for money”. University of Zurich is taking part with the exhibition TRANSACTIONS.Datascientist.ch is supporting this event through the ongoing research project of…

Continue reading →

The Silo Effect in Doctoral Education

The Silo Effect in Doctoral Education

Doctoral Education takes place across various organizational levels, including a wide variety of stakeholders. Yet, academic institutions are structured into functional departments, and information on Doctoral Education is often collected at multiple levels. This can result in isolated silos, where information is simply stacked–like a…

Continue reading →

We bring data science into clinical drug trials

We bring data science into clinical drug trials

Lately we came across a publication on clinical drug trials by Vanda Pogačić Kramp and Paul Herrling (DOI:10.1159/000318238) published in the journal Neurodegenerative Diseases in 2010. In essence the paper lists drugs in development for neurodegenerative diseases over 50 pages with about 700 single entries….

Continue reading →

Page 1 of 3 1 2 3